A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: BIOLOGICAL: UB-921|BIOLOGICAL: Herceptin
Sponsor: United BioPharma
Collaborators: Tri-Service General Hospital